Developing AI-based Strategies to Leverage Imaging & Functional Biomarkers in Patient Selection for Geography Atrophy Trials
Time: 11:00 am
day: Conference Day Two
Details:
- Discussing the pioneering work in developing OCT-based imaging and other diagnostic tools for more objective, faster biomarkers and functional endpoints
- Establishing the current endpoints for geographic atrophy, measuring the death of RPE and photoreceptor cells, predict lesion growths and functional outcomes for regulatory approvals
- Uncovering the recent advancements in imaging GA by using AI algorithms to measure the extent of dead photoreceptor and RPE cells and identifying the right patients for treatment in clinical trials
